Patents by Inventor Robert A. Reed

Robert A. Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11774494
    Abstract: Systems and methods are provided for testing a threshold energy required to cause a latchup on an electronic component. An exemplary method includes applying a series of laser pulses to a testing object with a pulsed laser unit. The testing object is connected to a testing circuit which can measure the energy of each of the series of laser pulses, and detect whether a pulse of the series of laser pulses resulted in a latchup on the testing object. Upon detecting the pulse, the method provides for logging the energy of the pulse using a recording unit and logging the latchup status of the test device. If a latchup is detected, the testing circuit automatically mitigates the latchup event.
    Type: Grant
    Filed: August 10, 2022
    Date of Patent: October 3, 2023
    Assignee: VANDERBILT UNIVERSITY
    Inventors: Andrew L. Sternberg, Ronald D. Schrimpf, Robert A. Reed
  • Publication number: 20220390511
    Abstract: Systems and methods are provided for testing a threshold energy required to cause a latchup on an electronic component. An exemplary method includes applying a series of laser pulses to a testing object with a pulsed laser unit. The testing object is connected to a testing circuit which can measure the energy of each of the series of laser pulses, and detect whether a pulse of the series of laser pulses resulted in a latchup on the testing object. Upon detecting the pulse, the method provides for logging the energy of the pulse using a recording unit and logging the latchup status of the test device. If a latchup is detected, the testing circuit automatically mitigates the latchup event.
    Type: Application
    Filed: August 10, 2022
    Publication date: December 8, 2022
    Inventors: Andrew L. STERNBERG, Ronald D. SCHRIMPF, Robert A. REED
  • Patent number: 11435399
    Abstract: Systems and methods are provided for testing a threshold energy required to cause a latchup on an electronic component. An exemplary method includes applying a series of laser pulses to a testing object with a pulsed laser unit. The testing object is connected to a testing circuit which can measure the energy of each of the series of laser pulses, and detect whether a pulse of the series of laser pulses resulted in a latchup on the testing object. Upon detecting the pulse, the method provides for logging the energy of the pulse using a recording unit and logging the latchup status of the test device. If a latchup is detected, the testing circuit automatically mitigates the latchup event.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: September 6, 2022
    Assignee: Vanderbilt University
    Inventors: Andrew L. Sternberg, Ronald D. Schrimpf, Robert A. Reed
  • Publication number: 20190391203
    Abstract: Systems and methods are provided for testing a threshold energy required to cause a latchup on an electronic component. An exemplary method includes applying a series of laser pulses to a testing object with a pulsed laser unit. The testing object is connected to a testing circuit which can measure the energy of each of the series of laser pulses, and detect whether a pulse of the series of laser pulses resulted in a latchup on the testing object. Upon detecting the pulse, the method provides for logging the energy of the pulse using a recording unit and logging the latchup status of the test device. If a latchup is detected, the testing circuit automatically mitigates the latchup event.
    Type: Application
    Filed: February 8, 2018
    Publication date: December 26, 2019
    Inventors: Andrew L. STERNBERG, Ronald D. SCHRIMPF, Robert A. REED
  • Patent number: 10251901
    Abstract: The present invention relates to a formulation of thermosensitive liposomes, and more specifically to a formulation of liposomes comprising phospholipids and a surface active agent, wherein the liposomes support long term storage at temperatures less than or equal to about 8° C., control degradate formation to maximize product potency and release their contents at mild hyperthermic temperatures. Methods of making formulations are also described.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: April 9, 2019
    Assignee: Celsion Corporation
    Inventors: Robert A. Reed, Daishui Su
  • Publication number: 20170080003
    Abstract: The present invention relates to a formulation of thermosensitive liposomes, and more specifically to a formulation of liposomes comprising phospholipids and a surface active agent, wherein the liposomes support long term storage at temperatures less than or equal to about 8° C., control degradate formation to maximize product potency and release their contents at mild hyperthermic temperatures. Methods of making formulations are also described.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 23, 2017
    Inventors: Robert A. Reed, Daishui SU
  • Publication number: 20130230457
    Abstract: The present invention relates to a formulation of thermosensitive liposomes, and more specifically to a formulation of liposomes comprising phospholipids and a surface active agent, wherein the liposomes support long term storage at temperatures less than or equal to about 8° C., control degradate formation to maximize product potency and release their contents at mild hyperthermic temperatures. Methods of making formulations are also described.
    Type: Application
    Filed: February 15, 2013
    Publication date: September 5, 2013
    Applicant: CELSION CORPORATION
    Inventors: Robert A. REED, Daishui SU
  • Patent number: 8450372
    Abstract: The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: May 28, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jeannie Chow Wong, Aaron S. Cote, Erik A. Dienemann, Kimberly Gallagher, Craig Ikeda, Justin Moser, Pavol Rajniak, Robert A. Reed, Cindy Starbuck, Hsien-Hsin Tung, Qingxi Wang, Benjamin Max Cohen, Vincent R. Capodanno, Brian Sell, Thomas A. Miller
  • Patent number: 8288440
    Abstract: The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: October 16, 2012
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jeannie Chow Wong, Aaron S. Cote, Erik A. Dienemann, Kimberly Gallagher, Craig Ikeda, Justin Moser, Pavol Rajniak, Robert A. Reed, Cindy Starbuck, Hsien-Hsin Tung, Qingxi Wang, Benjamin Max Cohen, Vincent R. Capodanno, Brian Sell
  • Patent number: 8093295
    Abstract: The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: January 10, 2012
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Jeannie Chow Wong, Benjamin Max Cohen, Aaron S. Cote, Erik A. Dienemann, Kimberly Gallagher, Craig Ikeda, Justin Moser, Pavol Rajniak, Robert A. Reed, Brian Sell, Cindy Starbuck, Hsien-Hsin Tung, Qingxi Wang, Vincent R. Capodanno
  • Publication number: 20100119596
    Abstract: The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
    Type: Application
    Filed: January 13, 2010
    Publication date: May 13, 2010
    Inventors: Jeannie Chow Wong, Aaron S. Cote, Erik A. Dienemann, Kimberly Gallagher, Craig Ikeda, Justin Moser, Pavol Rajniak, Robert A. Reed, Cindy Starbuck, Hsien-Hsin Tung, Qingxi Wang, Benjamin Max Cohen, Vincent R. Capodanno, Brian Sell
  • Publication number: 20100112046
    Abstract: The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
    Type: Application
    Filed: January 13, 2010
    Publication date: May 6, 2010
    Inventors: Jeannie Chow Wong, Aaron S. Cote, Erik A. Dienemann, Kimberly Gallagher, Craig Ikeda, Justin Moser, Pavol Rajniak, Robert A. Reed, Cindy Starbuck, Hsien-Hsin Tung, Qingxi Wang, Benjamin Max Cohen, Vincent R. Capodanno, Brian Sell
  • Patent number: 7400400
    Abstract: The present invention provides methods for the use of visible and/or near-infrared spectroscopic methodology to monitor and control processes for the generation of particles, including processes that provide for a reduction in particle size and processes that result in an increase in particle size. One embodiment of the present invention employs visible and/or near-infrared diffuse reflectance spectroscopy to monitor particle size. The present invention is particularly useful for monitoring particle size of optically dense samples and is further useful for monitoring the endpoint of particle generation processes. In contrast to methods known in the art, the present invention is especially useful for on-line monitoring of particle size.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: July 15, 2008
    Assignee: Merck & Co. Inc.
    Inventors: Steven M. Arrivo, William E. Bowen, Robert A. Reed, John P. Higgins
  • Publication number: 20080132575
    Abstract: The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.
    Type: Application
    Filed: May 16, 2006
    Publication date: June 5, 2008
    Inventors: Jeannie Chow Wong, Aaron S. Cote, Erik A. Dienemann, Kimberly Gallagher, Craig Ikeda, Justin Moser, Pavol Rajniak, Robert A. Reed, Cindy Starbuck, Hsien-Hsin Tung, Qingxi Wang, Benjamin Max Cohen, Vincent R. Capodanno, Brian Sell, Thomas A. Miller
  • Patent number: 6015716
    Abstract: Endotoxin incorporated into liposomes, lipid bilayers or lipid complexes can be detected by combining an aqueous suspension of the liposomes, lipid complexes or lipid bilayers with a suitable detergent. Preferable detergents, e.g., Lubrol-PX.TM. or a polyoxyethylene ether, solubilize the lipid bilayers, liposomes or lipid complexes at acceptable lipid concentrations, forming micelles therefrom which contain lipid bilayer, liposome or lipid complex lipid, detergent and endotoxin, should it be present. The micelles are then assayed for the presence of endotoxin.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: January 18, 2000
    Assignee: The Liposome Company, Inc.
    Inventors: Paul A. Harmon, Donna J. Cabral-Lilly, J. Craig Franklin, Robert A. Reed, Andrew S. Janoff
  • Patent number: 5596199
    Abstract: Apparatus and method for qualitatively and quantitatively analyzing a complex radiation field are provided. A passive microdosimetry detector device records the energy deposition of incident radiation using an array of microstructure non-volatile memory devices. Each microstructure non-volatile memory device is capable of storing a predetermined initial charge without requiring a power source. A radiation particle incident to a microstructure non-volatile memory device is termed an "event". Each such event may generate a charge within a sensitive volume defined by the microstructure non-volatile memory device. The charge generated within the sensitive volume alters the stored initial charge by an amount falling within a range corresponding to the energy deposited by certain particle types. Data corresponding to such charge alterations for a plurality of microstructure non-volatile memory devices within an array of such devices are presented to a qualitative analyzing device.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: January 21, 1997
    Assignee: Clemson University
    Inventors: Peter J. McNulty, W. Joseph Beauvais, David R. Roth, Wanda K. Moran, Robert A. Reed
  • Patent number: 5321267
    Abstract: A noncontact bench flotation sensor system for use with a flotation bench. The system comprises a plurality of reflectors that are disposed on the body of the bench, typically on the inside of the skirt or overhanging portion of the table surface of the bench. Each reflector is such that it reflects over a narrow region, or angle. Two sensor assemblies, preferably infrared, are disposed adjacent each reflector and are located on each leg of the bench. Each of the sensor assemblies is comprised of an transmitter and an detector. The two sensor assemblies are separated by a distance that corresponds to upper and lower limits of bench flotation. The sensor assemblies transmit infrared energy, for example, at the reflector. In the event that the isolator moves to a point where one of the transmitters is aligned with the reflector, energy is reflected back to the associated detector, and the reflected energy is detected.
    Type: Grant
    Filed: September 25, 1992
    Date of Patent: June 14, 1994
    Assignee: Hughes Aircraft Company
    Inventors: Lynden A. Song, Karl B. Conroy, Robert A. Reed
  • Patent number: 4132480
    Abstract: A photograhic cropping mask of a planar sheet, such as paper, plastic or cardboard, having defined therein a plurality of prescored, detachable rectilinear openings having a common center, indexing means and, optionally, an area of adhesive material and/or crop marks such that the sheet may be placed adjacent a transparent film to determine the cropping opening appropriate to the film image, the selected opening produced by detaching along an appropriate score line, the film attached by means of tape or the optional adhesive area to the sheet with the film properly aligned with the opening, and the film and sheet then accurately positioned in a photographic printing apparatus by the indexing means.
    Type: Grant
    Filed: July 5, 1977
    Date of Patent: January 2, 1979
    Inventor: Robert A. Reed